AS

Amrita Singh

Active Director Director DIN 08426935
DIN 08426935 First appointment Mar 2019 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2019
Shareholding value •••• Premium profile

About Amrita Singh

Data last updated:

Amrita Singh is a Director at Devout Pharmaceuticals Private Limited (since 2019). The company operates in Trading. Devout Pharmaceuticals Private Limited reported revenue of ₹1.1 Lakh (FY 2025).

DIN 08426935
Primary Designation Director
Industry Trading
First Appointment 19 Mar 2019
Oldest Company Age 13 yrs
Largest company Devout Pharmaceuticals Private Limited · ₹1.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Mar 20192012₹1.1 Lakh (FY 2025)Active

Board colleagues of Amrita Singh

NameDINCompanyDesignation
Sanjay Kumar Shahi07352929Devout Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Devout Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Amrita Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amrita Singh

Amrita Singh currently holds 1 directorship: Devout Pharmaceuticals Private Limited (Director, since 19 Mar 2019, revenue ₹1.1 Lakh (FY 2025)).

Amrita Singh was first appointed on 19 Mar 2019 as Director at Devout Pharmaceuticals Private Limited.

The current boards of Amrita Singh's companies include Sanjay Kumar Shahi (Devout Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available